Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.
AVANOS MEDICAL, INC. (AVNS) had Consolidated Net Income/Loss of $-1.40M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$177.80M |
|
$-1.40M |
|
$91.80M |
|
$86.00M |
|
$177.70M |
|
$0.10M |
|
$-1.30M |
|
$-1.20M |
|
$-1.20M |
|
$-1.40M |
|
$-1.40M |
|
|
Consolidated Net Income/Loss |
$-1.40M |
$-1.40M |
|
$0.10M |
|
$9.50M |
|
46.40M |
|
46.40M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$351.40M |
|
$115.40M |
|
$716.30M |
|
$1.07B |
|
$147.90M |
|
$93.40M |
|
$141.80M |
|
$289.70M |
|
$778.00M |
|
$261.60M |
|
$778.00M |
|
46.42M |
|
| Cash Flow Statement Financials | |
$46.50M |
|
$-53.80M |
|
$-34.30M |
|
$107.70M |
|
$70.50M |
|
$-37.20M |
|
$11.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.38 |
|
-- |
|
-- |
|
0.11 |
|
0.13 |
|
48.37% |
|
0.06% |
|
0.06% |
|
-- |
|
-0.67% |
|
-0.79% |
|
$25.80M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
0.61 |
|
1.59 |
|
56.44 |
|
-0.18% |
|
-0.54% |
|
-0.13% |
|
-0.16% |
|
$16.76 |
|
$0.56 |
|
$1.00 |
|